DBS Evaluation of Fujirebio INNOTEST® HCV Ab IV
Clinical trial NCT04317729 · COMPLETED
Trial details
- NCT number
- NCT04317729
- Sponsor
- Foundation for Innovative New Diagnostics, Switzerland
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-30
- Primary completion
- 2020-04-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.